FDA Inspection 854767 — Opto-Pharm Pte Ltd.

Opto-Pharm Pte Ltd. — FEI 3005320466

The FDA completed an inspection of Opto-Pharm Pte Ltd. on June 24, 2013 in Singapore. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 24, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Singapore (Singapore)